Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

BUY
$24.36 - $28.18 $232,686 - $269,175
9,552 Added 83.39%
21,006 $519,000
Q2 2023

Aug 04, 2023

SELL
$21.38 - $29.19 $72,264 - $98,662
-3,380 Reduced 22.79%
11,454 $324,000
Q1 2023

Apr 27, 2023

BUY
$21.74 - $30.93 $322,491 - $458,815
14,834 New
14,834 $340,000
Q3 2022

Nov 04, 2022

BUY
$19.51 - $34.14 $117,001 - $204,737
5,997 Added 61.13%
15,807 $447,000
Q2 2022

Aug 03, 2022

BUY
$17.06 - $31.42 $167,358 - $308,230
9,810 New
9,810 $217,000
Q1 2022

May 02, 2022

SELL
$26.68 - $34.81 $113,656 - $148,290
-4,260 Closed
0 $0
Q4 2021

Feb 23, 2022

SELL
$29.58 - $49.78 $43,038 - $72,429
-1,455 Reduced 25.46%
4,260 $140,000
Q3 2021

Oct 28, 2021

SELL
$41.92 - $58.18 $67,365 - $93,495
-1,607 Reduced 21.95%
5,715 $322,000
Q2 2021

Aug 12, 2021

BUY
$52.06 - $61.27 $381,183 - $448,618
7,322 New
7,322 $403,000
Q1 2021

Apr 26, 2021

SELL
$44.23 - $57.5 $589,895 - $766,877
-13,337 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$33.21 - $46.54 $379,324 - $531,579
11,422 Added 596.45%
13,337 $577,000
Q3 2020

Oct 14, 2020

SELL
$33.87 - $55.93 $9,077 - $14,989
-268 Reduced 12.28%
1,915 $67,000
Q2 2020

Jul 13, 2020

BUY
$34.45 - $53.48 $75,204 - $116,746
2,183 New
2,183 $116,000
Q4 2019

Feb 05, 2020

SELL
$30.08 - $50.59 $813,272 - $1.37 Million
-27,037 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$32.4 - $49.58 $875,998 - $1.34 Million
27,037 New
27,037 $875,000
Q2 2019

Jul 26, 2019

SELL
$46.17 - $68.1 $52,310 - $77,157
-1,133 Closed
0 $0
Q1 2019

Apr 18, 2019

SELL
$45.92 - $67.67 $447,352 - $659,241
-9,742 Reduced 89.58%
1,133 $0
Q4 2018

Jan 16, 2019

BUY
$42.73 - $76.53 $275,907 - $494,154
6,457 Added 146.15%
10,875 $501,000
Q3 2018

Oct 23, 2018

SELL
$71.67 - $91.95 $1.45 Million - $1.86 Million
-20,260 Reduced 82.1%
4,418 $340,000
Q2 2018

Jul 30, 2018

BUY
$73.22 - $99.55 $618,269 - $840,600
8,444 Added 52.01%
24,678 $2.08 Million
Q1 2018

Apr 26, 2018

BUY
$59.83 - $86.53 $552,829 - $799,537
9,240 Added 132.11%
16,234 $1.33 Million
Q4 2017

Jan 10, 2018

BUY
$52.12 - $72.33 $362,598 - $503,199
6,957 Added 18802.7%
6,994 $399,000
Q3 2017

Oct 25, 2017

BUY
$54.89 - $67.12 $2,030 - $2,483
37
37 $2,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.